Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Non Operating Income (2022 - 2025)

Historic Non Operating Income for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Q3 2025 value amounting to -$14.7 million.

  • Phathom Pharmaceuticals' Non Operating Income rose 53.45% to -$14.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.1 million, marking a year-over-year decrease of 1854.62%. This contributed to the annual value of -$56.9 million for FY2024, which is 6586.64% down from last year.
  • Per Phathom Pharmaceuticals' latest filing, its Non Operating Income stood at -$14.7 million for Q3 2025, which was up 53.45% from -$15.9 million recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Non Operating Income registered a high of -$2.8 million during Q1 2022, and its lowest value of -$15.9 million during Q2 2025.
  • Over the past 4 years, Phathom Pharmaceuticals' median Non Operating Income value was -$9.7 million (recorded in 2023), while the average stood at -$10.8 million.
  • Within the past 5 years, the most significant YoY rise in Phathom Pharmaceuticals' Non Operating Income was 1142.26% (2023), while the steepest drop was 18042.77% (2023).
  • Phathom Pharmaceuticals' Non Operating Income (Quarter) stood at -$8.4 million in 2022, then dropped by 15.35% to -$9.7 million in 2023, then crashed by 55.07% to -$15.0 million in 2024, then rose by 2.21% to -$14.7 million in 2025.
  • Its Non Operating Income stands at -$14.7 million for Q3 2025, versus -$15.9 million for Q2 2025 and -$15.5 million for Q1 2025.